Literature DB >> 9035449

[Precision and accuracy of blood lipid analyses by a portable device (Cholestech-LDX)].

J S Issa1, C Strunz, S D Giannini, N Forti, J Diament.   

Abstract

PURPOSE: To verify whether precision and accuracy of lipids analyses by a new portable device, Cholestech-lipid desktop analyzer (LDX), were in agreement with the guidelines of the National Cholesterol Education Program (NCEP).
METHODS: Serum samples from 45 outpatients were collected for the determination of total Cholesterol (TC), HDL-cholesterol (HDL-C) and triglycerides (TG). These samples were analysed simultaneously by the Cholestech-LDX, and by the automatic enzymatic methods routinely used at the Heart Institute's laboratory. Precision was determined by repeating 20 times the evaluation of the same sample of venous blood. Accuracy was established confronting the values of the lipids variables obtained with Cholestech-LDX against the values determined by the automatic enzymatic routine.
RESULTS: Accuracy for TC was 1.60% (NCEP < or = 3%), for HDL-C was -2.74% (NCEP < or = 6%) and for TG was 2.11% (NCEP < or = 5%). Precision for CT was 3.05% (NCEP < or = 3%), for HDL-C was 1.05% (NCEP < or = 6%) and for TG was 2.65% (NCEP < 5%).
CONCLUSION: Precision and accuracy of lipids evaluation by the Cholestech-LDX are within the guidelines of the National Cholesterol Education Program. Therefore the cholestech-LDX seems to be a reliable alternative to the conventional biochemical routine, allowing population screenings.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9035449

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  6 in total

1.  A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial.

Authors:  Karen Broekhuizen; Mireille N M van Poppel; Lando L J Koppes; Johannes Brug; Willem van Mechelen
Journal:  BMC Public Health       Date:  2010-02-15       Impact factor: 3.295

2.  No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with familial hypercholesterolemia compared to usual care: results of a randomised controlled trial.

Authors:  Karen Broekhuizen; Mireille N M van Poppel; Lando L Koppes; Iris Kindt; Johannes Brug; Willem van Mechelen
Journal:  BMC Res Notes       Date:  2012-07-04

3.  Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with familial hypercholesterolemia?

Authors:  Karen Broekhuizen; Judith G M Jelsma; Mireille N M van Poppel; Lando L J Koppes; Johannes Brug; Willem van Mechelen
Journal:  BMC Public Health       Date:  2012-05-14       Impact factor: 3.295

4.  Several steps/day indicators predict changes in anthropometric outcomes: HUB City Steps.

Authors:  Jessica L Thomson; Alicia S Landry; Jamie M Zoellner; Catrine Tudor-Locke; Michael Webster; Carol Connell; Kathy Yadrick
Journal:  BMC Public Health       Date:  2012-11-15       Impact factor: 3.295

5.  Can multiple lifestyle behaviours be improved in people with familial hypercholesterolemia? Results of a parallel randomised controlled trial.

Authors:  Karen Broekhuizen; Mireille N M van Poppel; Lando L Koppes; Iris Kindt; Johannes Brug; Willem van Mechelen
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

6.  Multicomponent intervention to reduce daily sedentary time: a randomised controlled trial.

Authors:  Lucas J Carr; Kristina Karvinen; Mallory Peavler; Rebecca Smith; Kayla Cangelosi
Journal:  BMJ Open       Date:  2013-10-18       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.